The complete remission rate is 80%! New bispecific CAR-T treatment of malignant hematological tumors.,The complete remission rate is 80%! ...
Day: April 25, 2021
FDA accelerates approval of GSK's new endometrial cancer drug: Jemperli FDA accelerates approval of GSK's new endometrial cancer drug: Jemperli. ...
Clinical research progress of AKT allosteric inhibitor TAS-117 for advanced solid tumors Progress of AKT allosteric inhibitor TAS-117 for...
Nature Cancer: EZH2 + PD-1 inhibitor to enhance the therapeutic effect of prostate cancer EZH2 + PD-1 inhibitor to...
Nature: Analysis of the long-term effects of new coronavirus pneumonia Nature: Analysis of the long-term effects of new coronavirus...
Milestone breakthrough! U.S. doctor completed human tracheal transplant for the first time U.S. doctor completed human tracheal transplant for...
India Coronavirus break out: The "triple mutation" was discovered for the first time India break out: The "triple mutation"...
Keytruda+Lenvima: "Immune + Targeted" treatment of uterine body cancer! Keytruda+Lenvima: "Immune + Targeted" treatment of uterine body cancer! The...
Lung cancer screening can predict heart disease? Lung cancer screening can predict heart disease? Using CT data from lung...
2021 New Antibody drug: Loncastuximab tesirine-lpyl (Zynlonta) 2021 New Antibody drug: Loncastuximab tesirine-lpyl (Zynlonta). On April 23, 2021, the...